Spots Global Cancer Trial Database for Study of AM003 in Patients With Locally Advanced and Metastatic Solid Tumors

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study of AM003 in Patients With Locally Advanced and Metastatic Solid Tumors

Official Title: A Phase I, Open-Label Multicenter Study of AM003 Dose Escalation, Administered Intratumorally to Patients With Locally Advanced and Metastatic Solid Tumors

Study ID: NCT06258330

Conditions

Solid Tumor

Interventions

AM003

Study Description

Brief Summary: This is a phase 1, first-in-human study to assess the safety and tolerability of AM003 in patients with locally advanced and metastatic solid tumors

Detailed Description: This is a phase 1, open-label , multicenter dose escalation trial evaluating the safety and tolerability of AM003 , administered intratumorally to patients with locally advanced and metastatic solid tumors